p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles

被引:0
|
作者
Chandrababu Rejeeth
Soundrapandian Kannan
机构
[1] School of Life Sciences,Proteomics and Molecular Cell Physiology Lab, Department of Zoology
[2] Bharathiar University,undefined
来源
Breast Cancer | 2016年 / 23卷
关键词
Silica nanoparticles; Gene delivery; Breast carcinoma; p53; Transferrin (Tf);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:101 / 110
页数:9
相关论文
共 50 条
  • [31] ALTERATIONS OF THE P53 GENE ARE ASSOCIATED WITH THE PROGRESSION OF A HUMAN PROSTATE CARCINOMA
    EFFERT, PJ
    NEUBAUER, A
    WALTHER, PJ
    LIU, ET
    JOURNAL OF UROLOGY, 1992, 147 (03): : 789 - 793
  • [32] ABERRATION OF THE P53 GENE IN HUMAN HEPATOCELLULAR-CARCINOMA IN JAPAN
    NISHIDA, N
    FUKUDA, Y
    KOMEDA, T
    SANDO, T
    KITA, R
    FURUKAWA, M
    NAKAO, AK
    HEPATOLOGY, 1994, 19 (04) : I109 - I109
  • [33] Transferrin-modified carboxymethyl chitosan-chitosan nanoparticles as an efficient delivery carrier for targeted therapy of depression
    He, Junhui
    Yang, Li
    Li, Dongmei
    Xie, Jiaxiu
    Zhou, Guili
    Zhou, Rongfei
    Li, Yi
    Wei, Guining
    Gong, Zhiqiang
    Li, Li
    Lai, Kedao
    Zhou, Juying
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 286
  • [34] Gene therapy with p53 or p21 adenovirus for hepatocellular carcinoma.
    Kanai, F
    Ikenoue, T
    Ohashi, M
    Tanaka, T
    Lan, KH
    Ueno, H
    Yoshida, H
    Kawabe, T
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 1997, 112 (04) : A1296 - A1296
  • [35] THE P53 GENE IN HUMAN CANCER
    STRATTON, MR
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (01) : 293 - 295
  • [36] P53 GENE IN HUMAN HEPATOCARCINOGENESIS
    OZTURK, M
    PONCHEL, F
    PUISIEUX, A
    MARCAIS, C
    PATHOLOGIE BIOLOGIE, 1993, 41 (01): : 21 - 21
  • [37] EXPRESSION OF THE RB AND P53 GENE-PRODUCTS IN BREAST-CARCINOMA
    TRUDEL, M
    MULLIGAN, L
    CAVENEE, W
    MARGOLESE, R
    COTE, J
    GARIEPY, G
    LABORATORY INVESTIGATION, 1991, 64 (01) : A14 - A14
  • [38] POOR-PROGNOSIS OF P53 GENE MUTATION AND NUCLEAR OVEREXPRESSION OF P53 PROTEIN IN INFLAMMATORY BREAST-CARCINOMA
    RIOU, G
    LE, MG
    TRAVAGLI, JP
    LEVINE, AJ
    MOLL, UM
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (21) : 1765 - 1767
  • [39] Combined effects of p53 gene therapy and leptomycin B in human esophageal squamous cell carcinoma
    Hoshino, Isamu
    Matsubara, Hisahiro
    Komatsu, Aki
    Akutsu, Yasunori
    Nishimori, Takanori
    Yoneyama, Yasuo
    Murakami, Kentaro
    Sakata, Haruhito
    Matsushita, Kazuyuki
    Miyazawa, Yukimasa
    Brooks, Ryan
    Yoshida, Minoru
    Ochiai, Takenori
    ONCOLOGY, 2008, 75 (1-2) : 113 - 119
  • [40] Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts
    Nielsen, LL
    Dell, J
    Maxwell, E
    Armstrong, L
    Maneval, D
    Catino, JJ
    CANCER GENE THERAPY, 1997, 4 (02) : 129 - 138